专家综述
通过筛查和早期发现,可以降低结直肠癌(CRC)的发病率,有效切除肿瘤病变可以降低CRC的病死率。虽然对CRC的危险因素、发病机制和前体病变的了解已经取得进展,但最近年轻人群CRC发病率升高,原因尚不清楚。在过去十年中,出现了多种侵入性、半侵入性和非侵入性筛查方式。目前对结肠镜检查质量的重视提高了筛查的有效性,人工智能等影像新技术在肿瘤检测中的作用正在迅速显现。而且,CRC有效干预措施,如保肛治疗新术式、靶向治疗及免疫治疗领域的新进展,被证明可以提高CRC患者的生存率。该文旨在总结目前国内外CRC筛查方式和指南的证据,并综述CRC治疗领域的进展。
The incidence of colorectal cancer(CRC)can be reduced through screening and early detection.Effective resection of tumor lesions reduces mortality from CRC.Although progress has been made in understanding the risk factors,pathogenesis and precursor lesions of CRC,the reasons for the recent increase in the incidence of CRC in young adults are largely unknown.A variety of invasive,semi-invasive and non-invasive screening modalities have emerged in the last decade.The current emphasis on the quality of colonoscopy has improved the effectiveness of screening,and the role of new imaging technologies such as artificial intelligence in tumor detection is rapidly emerging.Moreover,there are effective interventions for CRC,such as new surgical modalities for anal preservation therapy,and new advances in the field of targeted therapy and immunotherapy,which have been shown to improve the survival rate of CRC.The aim of this article is to summarize the current evidence on CRC screening modalities and guidelines both nationally and internationally,and to provide an overview of advances in the field of CRC treatment.
论著
目的 探讨血清胱抑素C(Cys-C)联合β2-微球蛋白(β2-MG)早期诊断糖尿病肾病的应用价值。方法 选择2021年4月—2023年4月医院接收的100例糖尿病患者为对象,根据其有无合并肾脏疾病,将其分为糖尿病组及糖尿病肾病组,各50例,同比例选取同期到我院体检的健康人群50名进行对照研究,检测比较其Cys-C及β2-MG水平,对比其Cys-C阳性率、β2-MG阳性率及联合检测阳性率,并对比不同疾病分期糖尿病肾病患者的Cys-C、β2-MG水平。结果 糖尿病肾病患者Cys-C、β2-MG水平高于糖尿病患者与健康者(P<0.05)。糖尿病患者Cys-C、β2-MG水平高于健康者(P<0.05)。糖尿病肾病患者Cys-C阳性率64.00%、β2-MG阳性率72.00%、Cys-C+β2-MG联合检测阳性率96.00%高于糖尿病6.00%、10.00%、12.00%及健康者0.00%、0.00%、0.00%(P<0.05);糖尿病Cys-C+β2-MG联合检测阳性率12.00%高于健康者0.00%(P<0.05);糖尿病肾病中Cys-C+β2-MG联合检测阳性率96.00%高于CysC 64.00%、β2-MG 72.00%(P<0.05)。糖尿病肾病不同分期患者Cys-C、β2-MG水平比较,Ⅳ期>Ⅲ期>Ⅰ~Ⅱ期(P<0.05)。结论 糖尿病肾病患者Cys-C、β2-MG水平明显升高,Cys-C、β2-MG联合诊断更具有优势,而且肾损害越严重,Cys-C、β2-MG异常程度越高,作为临床诊治的参考依据的价值较高。
Objective To investigate the application value of serum cystatin C(Cys-C)combined with β2-microglobulin(β2-MG)in the early diagnosis of diabetic nephropathy.Methods A total of 100 diabetic patients admitted to our hospital from April 2021 to April 2023 were selected as subjects,and divided into diabetes group and diabetic nephropathy group according to whether they have renal diseases or not,with 50 cases in each group.Then,50 healthy people who came to our hospital for physical examination in the same period were selected for comparative study,and their Cys-C and β2-MG levels were detected and compared,and their Cys-C positive rate,β2-MG positive rate and combined detection positive rate were compared.Results The levels of Cys-C and β2-MG in patients with diabetic nephropathy were higher than those in patients with diabetes and healthy controls(P<0.05).The levels of Cys-C and β2-MG in diabetic patients were higher than those in healthy controls(P<0.05).The positive rates of Cys-C(64.00%),β2-MG(72.00%)and Cys-C+β2-MG(96.00%)in patients with diabetic nephropathy were higher than those in patients with diabetes(6.00%,10.00%,12.00%)and healthy subjects(0.00%,0.00%,0.00%)(P<0.05).The positive rate of combined detection of Cys-C and β2-MG in diabetic patients(12.00%)was higher than that in healthy subjects(0.00%)(P<0.05).The positive rate of Cys-C combined with β2-MG in diabetic nephropathy was 96.00%,which was higher than that of Cys-C 64.00% and β2-MG 72.00%(P<0.05).The levels of Cys-C and β2-MG in patients with stage Ⅳ diabetic nephropathy were higher than those in patients with stage Ⅲ and Ⅰ-Ⅱ diabetic nephropathy(P<0.05).The levels of Cys-C and β2-MG in stage Ⅲ patients were higher than those in stage Ⅰ-Ⅱ patients(P<0.05).Conclusions The levels of Cys-C and β2-MG are significantly increased in patients with diabetic nephropathy,and the combination of Cys-C and β2-MG has more advantages.The greater serious renal damage,the greater abnormal degree of Cys-C and β2-MG,which has a higher value as a reference for clinical diagnosis and treatment.
专家综述
先天性巨结肠是遗传背景复杂的先天性肠神经系统发育异常性疾病,也是小儿外科临床工作中的常见疾病,以消化道末端肠神经节缺如为典型病理特点,肠梗阻、肠穿孔、严重的巨结肠相关性小肠结肠炎是疾病的主要并发症,尤其在低龄婴幼儿起病的病例中,仍是围术期死亡的主要原因。近些年来,越来越多的学者在解析其发病机制、遗传特征、治疗手段等方面不断探索创新,但在低龄婴幼儿,尤其是新生儿期寻找创伤小、特异性高、普适性强的早诊方法仍面临巨大挑战,早发现、早干预可以有效改善患儿的生活质量及疾病预后。本文对先天性巨结肠相关的早期诊断方法进行了系统综述,以期在传统经典的诊断方法上,不断创新求索,综合不同方法的利弊,提高临床应用中的诊断效能,为疾病早期诊断方面的研究提供理论基础。
临床诊疗
目的 研究联合电生理检查用于糖尿病周围神经病变早期诊断的价值。方法 选取160例糖尿病患者,根据患者是否存在肢体麻木、疼痛、无力、烧灼感或凉感等周围神经损伤临床症状,将患者分为有症状组84例,无症状组76例。所有患者均行电生理检查,检测神经传导(nerve conduction studies,NCS)及F波,检测指标包括运动神经运动末端潜伏期(distal motor latency,DML)、复合肌肉动作电位(compound muscle action potential,CMAP)波幅、感觉神经动作电位(sensory nerve action potentia,SNAP)波幅、感觉神经传导速度(sensory nerve conduction velocity,SCV)、F波平均潜伏期(Flmean)、F波离散度(Fchd)。比较2组电生理检查指标。结果 有症状组胫神经及腓总神经DML均高于无症状组(P<0.05),胫神经及腓总神经CAMP均低于无症状组(P<0.05)。有症状组正中神经、尺神经、胫神经及腓总神经SCV、SNAP均低于无症状组(P<0.05)。有症状组正中神经及胫神经Flmean、Fchd均高于无症状组(P<0.05)。NCS、F波联合诊断糖尿病周围神经病变的灵敏度为0.857、特异度0.829、准确率0.844、阳性预测值为0.847、阴性预测值为0.840、kappa值0.687。结论 糖尿病周围神经病变早期联合电生理检查具有一定价值。
论著
目的 探讨恙虫病患者血清乳酸脱氢酶(LDH)水平在检查中的临床价值及LDH与血小板数目、丙氨酸氨基转移酶和天冬氨酸氨基转移酶的相关性。方法 选取2016年3月—2018年2月在我院就诊的60例恙虫病患者,其中男25例,女35例。记录患者的基本情况,血常规、肝肾功能等实验室检测指标;并检测患者血清中乳酸脱氢酶水平。并分析患者乳酸脱氢酶与小板数目、丙氨酸氨基转移酶和天冬氨酸氨基转移酶的相关性。结果 多数患者出现发烧、头痛、腹痛、咳嗽咳痰等症状,少数患者出现腰痛、意识障碍、皮肤黏膜出血等症状;60例恙虫病患者中,52名患者血清乳酸脱氢酶含量高于正常值,15例患者血小板数量低于正常值;55名患者丙氨酸氨基转移酶高于正常值,53名患者天冬氨酸氨基转移酶高于正常值;患者血清LDH与血小板数目(r=-0.929,P<0.01)呈负相关,与丙氨酸氨基转移酶(r=0.957,P<0.01),天冬氨酸氨基转移酶(r=0.947,P<0.01)呈正相关。结论 乳酸脱氢酶水平可以作为患者恙虫病的早期诊断标志。
Objective To investigate the clinical value of serum LDH levels in tsutsugamushi patients. Methods We selected 60 patients with tsutsugamushi disease who were enrolled in our hospital from September 2016 to February 2018,including 25 males and 35 females. We recorded the patients' basic conditions,blood tests,liver and kidney function and other laboratory testing indicators;and we detected serum lactate dehydrogenase levels in patients. The correlations in lactate dehydrogenase and platelet number,alanine aminotransferase,and aspartate aminotransferase were analyzed. Results Most patients developed fever,headache,abdominal pain,cough,sputum,and other symptoms. A small number of patients suffered low back pain,disturbance of consciousness,skin mucosal bleeding,and other symptoms;among the 60 patients with tsutsugamushi disease,the contents of serum amblytic dehydrogenase were higher than normal in 52 patients,and the numbers of platelets in 15 patients were lower than normal. The value of alanine aminotransferase was higher than normal in 55 patients,and the value of aspartate aminotransferase was higher than normal in 53 patients;serum LDH and platelet counts (r=-0.929,P<0.01),alanine aminotransferase (r=0.957,P<0.01) and aspartate aminotransferase (r=0.947,P<0.01) showed positive correlation. Conclusion Lactate dehydrogenase level may be used as an early diagnostic marker for patients with tsutsugamushi disease.
论著
目的 探讨多指标联合监测在冠心病(CHD)早期诊断中的应用。方法 选择2018年6月—2018年12月在我院就诊的患者180例,其中动脉硬化中低危人群60例(低危组),动脉硬化中高危人群60例(高危组),确诊的冠心病患者(CHD组),另选取健康体检者60例为对照组。分析血浆游离脂肪酸、高敏C反应蛋白、尿β-2微球蛋白、血清25羟维生素D及血脂水平与冠心病之间的关系。结果 低危组、高危组和CHD组患者FFA、hs-CRP、β2-MG、TC、TG、LDL-C水平均高于对照组,血清25羟维生素D3、HDL-C水平均低于对照组,差异均有统计学意义(P<0.05);低危组、高危组和CHD组患者的血清FFA、hs-CRP、β2-MG、TC、TG、LDL-C水平逐渐升高,血清25羟维生素D3、HDL-C逐渐降低,以CHD组最为显著。冠心病患者血清HDL-C的敏感度高于其他各指标(P<0.05);血清FFA、hs-CRP的特异度高于其他各指标(P<0.05)。结论 多指标联合检测对于早期诊断冠心病患者有一定意义。
Objective To explore the application of multi-index combined monitoring in early diagnosis of coronary heart disease (CHD). Methods 180 patients were selected from June 2018 to December 2018 in our hospital. Among them, 60 patients with middle and low risk of atherosclerosis (low risk group), 60 patients with middle and high risk of atherosclerosis (high risk group), 60 patients with confirmed coronary heart disease (CHD group), and 60 healthy people were selected as control group. The relationship between plasma free fatty acid, high sensitivity C-reactive protein, urinary β-2 microglobulin, serum 25-hydroxyvitamin D and blood lipid levels and coronary heart disease was analyzed. Results The levels of FFA, hs-CRP, beta 2-MG, TC, TG and LDL-C in low-risk group, high-risk group and CHD group were higher than those in control group, and serum levels of 25-hydroxyvitamin D3 and HDL-C were lower than those in control group (P<0.05). The levels of FFA, hs-CRP, beta 2-MG, TC, TG and LDL-C in low-risk group, high-risk group and CHD group increased gradually, while serum levels of 25-hydroxyvitamin D3, H-MG, TC, TG and LDL-C increased gradually. DL-C decreased gradually, especially in CHD group. The sensitivity of serum HDL-C in patients with coronary heart disease was higher than that of other indicators (P<0.05), and the specificity of serum FFA and hs-CR P was higher than that of other indicators (P<0.05). Conclusion The combined detection of multiple indicators has certain significance for the early diagnosis of coronary heart disease.
论著
目的 探讨及比较CURB-65、PSI、SMART-COP及APACHEⅡ 4种临床评分对重症社区获得性肺炎(SCAP)患者的早期诊断价值。方法 采用前瞻性研究方法,收集2011年10月—2014年2月广州市第一人民医院呼吸内科收治的67例SCAP及同期33例普通CAP患者的临床资料,记录入组后24小时内CURB-65、PSI、SMART-COP及APACHEⅡ评分的最差值,比较4种临床评分系统对SCAP的早期诊断价值。结果 SCAP组CURB-65、PSI、SMART-COP及APACHEⅡ评分均高于普通CAP组患者[CURB-65(分):3.06±1.10 比0.85±0.79,P<0.001;PSI(分):144.93±36.48比73.94±27.17,P<0.001; SMART-COP(分):6.54±1.41比 1.67±1.02,P<0.001; APACHEⅡ(分):20.79±5.69比7.94±3.87,P<0.001]。CURB-65≥3分、PSI≥130分、SMART-COP≥3分及APACHEⅡ≥15分诊断SCAP的受试者工作特征曲线(ROC)下面积(AUC)分别为0.940[95% CI:0.89~0.98, P<0.001],0.933[95%CI:0.88~0.97,P<0.001],0.999[95%CI:0.99~1.0,P<0.001],0.976[95%CI:0.95~0.99,P<0.001],敏感度分别为65.6%、71.6%、100%、88.1%,特异度分别为100%、100%、78.7%、93.9%。结论 CURB-65及PSI评分特异度好,但敏感度低,易漏诊,SMART-COP和APACHE Ⅱ评分诊断效能更佳。
Objective To evaluate and compare the early diagnosis value of CURB-65,PSI,SMART-COP and APACHEⅡin patients with severe community-acquired pneumonia. Methods This was a prospective study conducted in department of respiratory in Guangzhou First People's Hospital. We included 67 SCAP patients and 33 CAP patients between October of 2011and February of 2014. The lowest scores within 24 hours of CURB-65 score,PSI score,SMART-COP score,APACHE Ⅱ score,respectively,for each patients were recorded. Prediction of SCAP as made in four scoring systems was compared. Results CURB-65 score,PSI score,SMART-COP score,APACHE Ⅱ score were higher in SCAP as compared with that of CAP(CURB-65:3.0±1.1 vs 0.9±0.8,P<0.001;PSI:144.6±36.4 vs 73.9±27.1,P<0.001; SMART-COP:6.5±1.4 vs 1.6±1.0,P<0.001; APACHEⅡ:20.6±5.6 vs 7.9±3.8,P<0.001). ROC curve for CURB-65 score≥ 3 scores,PSI score≥ 130 scores,SMART-COP score≥3 scores and APACHE Ⅱ score ≥ 15 scores in the early diagnosis SCAP were 0.940[95%CI:0.89~0.98,P<0.001],0.933[95%CI:0.88~0.97,P<0.001],0.999[95%CI:0.99~1.0,P<0.001],0.976[95%CI:0.95~0.99,P<0.001]. Sensitivity of four kinds of scoring system was 65.6%,71.6%,100%,88.1%, with specificity of 100%,100%,78.7%,93.9% respectively. Conclusion The specificity of diagnosis was better in the CURB-65 and PSI score,but the sensitivity was low and easy to miss diagnosis. SMART-COP and APACHEⅡscore systems had a better diagnostic value on SCAP.
论著
目的 探讨呼出气体中丙酮能否用于糖尿病肾病的早期诊断。方法 对健康对照组、2型糖尿病组(T2MD)和糖尿病肾病组(DN)分别采用气相色谱-质谱(GC-MS)法测定呼气丙酮含量、全自动生化仪的乳胶透射免疫比浊法测定尿微量白蛋白、酶速率法测试β-羟丁酸以及全自动尿液分析仪干化学法测定尿酮体,并对上述结果进行分析。结果 在T2MD组和DN组中呼气中的丙酮含量均高于健康对照组(P<0.01);在DN组,丙酮与尿微量白蛋白水平呈线性相关(r=0.79,P<0.05)。结论 检测呼气中的丙酮有助于糖尿病肾病的早期诊断,能及时反映病人肾脏损伤情况。
Objective To explore the early diagnosis of diabetic nephropathy by exhaled acetone. Methods Respectively using GC-MS method for the determination of exhaled acetone content, emulsion transmission turbidimetric immunoassay method in automatic biochemical analyzer for determination of urinary microalbumin, enzyme rate method for testing β-hydroxybutyric acidand and dry chemical method in urine automatic analyzer for determination of urine ketone on healthy control group, type-2 diabetes mellitus group(T2MD), and diabetic nephropathy group(DN), and the above results were analyzed. Results The exhale acetone level in T2MD and DN groups were higher than those in control group(P<0.01); In DN group, the level of exhale acetone with urinary microalbumin had a linear correlation. Conclusion The detection of exhale acetone is helpful to early diagnosis in diabetic nephropathy, also may reflect the renal injury promptly.
论著
目的 通过检测结直肠癌患者血清及组织中癌胚抗原(CEA)及β2微球蛋白(β2MG)的表达,探讨结合两者在结直肠癌诊断中的作用。方法 对30例结直肠癌患者的血清、癌组织和癌旁组织进行CEA及β2MG检测,设置对照组为行肠镜检查的正常健康体检者30例。分别对比CEA及β2MG在结直肠癌中的关系,进一步对比CEA及β2MG两者在结直肠癌在结直肠癌患者中的肿瘤大小、分期、浸润深度及转移的关系。 同时对结直肠癌及健康体检者的一般情况如性别、年龄、CEA、β2MG、血红蛋白及白蛋白进行对比,以进一步了解CEA及β2MG 在结直肠癌中的重要性。结果 CEA在结直肠癌患者癌组织、癌旁组织及血清中升高的比例为100%、10%、47%;β2MG在结直肠癌患者癌组织、癌旁组织及血清升高的比例为60%、57%、23%;联合血清中CEA及β2MG升高的比例为63%;正常对照组中的CEA升高的比例为33%,β2MG升高的比例为67%;无论CEA还是β2MG在结直肠癌中均有一定比例的升高,联合两者升高更明显。结论 CEA及β2MG是恶性肿瘤特别是结直肠癌的重要指标,联合两者的检测提高结直肠癌的早期诊断。
Objective To detect the expression of carcinoembryonic antigen and β2 microglobulin in serum and tissue of patients with colorectal cancer, and to explore their roles in the diagnosis of colorectal cancer. Methods 30 patients with colorectal cancer were examined for CEA and β2MG in serum, cancer and para-cancer tissues, and 30 healthy persons with normal colonoscopy were selected as the control group. The expressions of CEA and β2MG in serum and tissues were compared, and the relationship between CEA and β2MG and tumor size, stage, depth of invasion and metastasis were analyzed. Results The increased in proportion of CEA in cancer tissue、para-carcinoma tissue and serum of colorectal cancer was 100%、10%、47%; Similarly, the increased in proportion of β2MG was 60%、57%、23%;Combined calculation the increased in proportion ofCEA and β2MG in serum of colorectal cancer was 63%;In the normal control, the increased in proportion of CEA was 33%;The increased in proportion of β2MG was 67%.Both CEA and β2MG in colorectal cancer had a certain proportion, the rise of joint both was obviously more. Conclusion CEA and β2MG are important markers of malignancy, especially colorectal cancer. Combined detection of CEA and β2MG can improve the early diagnosis of colorectal cancer.